Multicenter Cohort Study of AAV in Hunan of China

Recruiting now

Conditions studied: ANCA Associated Vasculitis

In brief

This study aimed to explore the incidence of Anti-neutrophil cytoplasmic antibody (ANCA）-associated vasculitis (AAV) progression and its association with adverse consequences. It will enroll approximately 500 AAV patients in Hunan province of China and follow-up for at least 5 years. Demographic characteristics, clinical and laboratory data will be collected at baseline and every follow-up. The principal clinical outcomes of the study consist of end stage renal disease (ESRD) and death.

Key facts

Study ID

NCT05315141

Run by

Xiangya Hospital of Central South University

People needed

500

Starts

2022-03-16

Expected to finish

2027-03-16

Last updated by the study team

2022-04-07

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Fulfill 2012 criteria of ANCA associated vasculitis and agree to sign informed consent

You may not qualify if…

• Do not agree to sign informed consent

Where it is running

• Xiangya hospital — Changsha, Hunan, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.